Developing a research diagnostic criteria for burning mouth syndrome: Results from an international Delphi process.

burning mouth syndrome oral dysaesthesia glossodynia orofacial pain research diagnostic criteria stomatodynia

Journal

Journal of oral rehabilitation
ISSN: 1365-2842
Titre abrégé: J Oral Rehabil
Pays: England
ID NLM: 0433604

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 23 07 2020
revised: 30 09 2020
accepted: 30 10 2020
pubmed: 7 11 2020
medline: 5 3 2021
entrez: 6 11 2020
Statut: ppublish

Résumé

To develop a beta version of a preliminary set of empirically derived research diagnostic criteria (RDC) for burning mouth syndrome (BMS) through expert consensus, which can then be taken into a test period before publication of a final RDC/BMS. A 6 round Delphi process with twelve experts in the field of BMS was used. The first round formed a focus group during which the purpose of the RDC and the definition of BMS was agreed upon, as well as the structure and contents. The remaining rounds were carried out virtually via email to achieve a consensus of the beta version of the RDC/BMS. The definition of BMS was agreed to be 'an intraoral burning or dysaesthetic sensation, recurring daily for more than 2 hours per day over more than 3 months, without evident causative lesions on clinical examination and investigation'. The RDC was based upon the already developed and validated RDC/TMD and formed three main parts: patient self-report; examination; and psychosocial self-report. A fourth additional part was also developed listing aspirational biomarkers which could be used as part of the BMS diagnosis where available, or to inform future research. This Delphi process has created a beta version of an RDC for use with BMS. This will allow future clinical research within BMS to be carried out to a higher standard, ensuring only patients with true BMS are included. Further validation studies will be required alongside refinement of the RDC as trialling progresses.

Identifiants

pubmed: 33155292
doi: 10.1111/joor.13123
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

308-331

Subventions

Organisme : Department of Health
ID : NIHR-CS-011-003
Pays : United Kingdom

Informations de copyright

© 2020 John Wiley & Sons Ltd.

Références

International Headache Society. International Classification of Orofacial Pain. Cephalalgia. 2020;40:129-221.
McMillan R, Forssell H, Buchanan JA, Glenny A-M, Weldon JC, Zakrzewska JM. Interventions for treating burning mouth syndrome. Cochrane Database Syst Rev. 2016;11:1465-1858. https://doi.org/10.1002/14651858.CD002779.pub3
Bergdahl M, Bergdahl J. Burning mouth syndrome: prevalence and associated factors. J Oral Pathol Med. 1999;28(8):350-354.
Femiano F. Statistical survey of afferent pathologies during a 5-year study in the oral pathology Department at the Second University of Naples. Minerva Stomatol. 2002;51(3):73-78.
Lipton JA, Ship JA, Larach-Robinson D. Estimated prevalence and distribution of reported orofacial pain in the United States. J Am Dent Assoc. 1993;124(10):115-121.
Tammiala-Salonen T, Hiidenkari T, Parvinen T. Burning mouth in a Finnish adult population. Community Dent Oral Epidemiol. 1993;21(2):67-71.
Moghadam-Kia S, Fazel N. A diagnostic and therapeutic approach to primary burning mouth syndrome. Clin Dermatol. 2017;35(5):453-460.
Kohorst JJ, Bruce AJ, Torgerson RR, Schenck LA, Davis MDP. A population-based study of the incidence of burning mouth syndrome. Mayo Clin Proc. 2014;89(11):1545-1552.
Ben Aryeh H, Gottlieb I, Ish-Shalom S, David A, Szargel H, Laufer D. Oral complaints related to menopause. Maturitas. 1996;24(3):185-189.
de Souza IF, Mármora BC, Rados PV, Visioli F. Treatment modalities for burning mouth syndrome: a systematic review. Clin Oral Investig. 2018;22(5):1893-1905.
Ritchie A, Kramer JM. Recent Advances in the Etiology and Treatment of Burning Mouth Syndrome. J Dent Res. 2018;1:22034518782462.
Dowrkin SF, LeResche L. Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique. J Craniomandib Disord. 1992;6:301-355.
Schiffman E, Ohrbach R, Truelove E, et al. Diagnostic criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: Recommendations of the International RDC/TMD Consortium Network and Orofacial Pain Special Interest Group. J Oral Facial Pain Headache. 2014;28(1):6-27.
Ahmad M, Hollender L, Anderson Q, et al. Research diagnostic criteria for temporomandibular disorders (RDC/TMD): development of image analysis criteria and examiner reliability for image analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107(6):844-860.
Anderson GC, Gonzalez YM, Ohrbach R, et al. The research diagnostic criteria for temporomandibular disorders. Vi: Future directions. J Orofac Pain. 2010;24(1):79-88.
Look JO, John MT, Tai F, et al. The research diagnostic criteria for temporomandibular disorders. II: Reliability of axis I diagnoses and selected clinical measures. J Orofac Pain. 2010;24(1):25-34.
Schiffmann EL, Ohrbach R, Truelove EL, et al. The research diagnostic criteria for temporomandibular disorders. V: methods use to establish and validate revised Axis I algorithms. J Orofac Pain. 2010;24:63-78.
Look JO, Schiffmann EL, Truelove EL, Ahmad M. Reliability and validity of Axis 1 of the research diagnostic criteria for temporomandibular disorders (RDC/TMD) with proposed revisions. J Oral Rehabil. 2010;37:744-759.
Schiffman EL, Truelove EL, Ohrbach R, et al. Assessment of the validity of the research diagnostic criteria for temporomandibular disorders. I: overview and methodology. J Orofac Pain. 2010;24(1):7-24.
Truelove E, Pan W, Look JO, et al. The research diagnostic criteria for temporomandibular disorders. III: validity of axis I diagnoses. J Orofac Pain. 2010;24(1):35-47.
Ohrbach R, Turner JA, Sherman JJ, et al. Research diagnostic criteria for temporomandibular disorders. IV: evaluation of psychometric properties of the axis II measures. J Orofac Pain. 2010;24(1):48-62.
Ohrbach R, Dworkin SF. The evolution of TMD diagnosis: Past, present, future. J Dent Res. 2016;95(10):1093-1101.
Deyo RA, Dworkin SF, Amtmann D, et al. Report of the NIH task force on research standards for chronic low back pain. Spine. 2014;39:1128-1143.
Fillingim RB, Bruehl S, Dworkin RH, et al. The acttion-american pain society pain taxonomy (aapt): An evidence-based and multidimensional approach to classifying chronic pain conditions. J Pain. 2014;15(3):241-249.
Nixdorf DR, Drangsholt MT, Ettlin DA, et al. Classifying orofacial pains: a new proposal of taxonomy based on ontology. J Oral Rehab. 2012;39:161-169.
Durham J, Al-Baghdadi M, Baad-Hansen L, et al. Self-management programmes in temporomandibular disorders: results from an international Delphi process. J Oral Rehabil. 2016;43(12):929-936.
Cramer C, Klasser G, Epstein J, Sheps S. The delphi process in dental research. J Evid Based Dent Pr. 2008;8:211-220.
Hsu C, Sandford B. The Delphi technique: making sense of consensus. Pr Assess. 2007;12:1-8.
Scheuermann RH, Ceusters W, Smith B. Toward an ontological treatment of disease and diagnosis. Summit Transl Bioinform. 2009;2009:116-120.
Tvarijonaviciute A, Aznar-Cayuela C, Rubio CP, Ceron JJ, Lopez-Jornet P. Evaluation of salivary oxidate stress biomarkers, nitric oxide and C-reactive protein in patients with oral lichen planus and burning mouth syndrome. J Oral Pathol Med. 2017;46(5):387-392. https://doi.org/10.1111/jop.12522
Borelli V, Marchioli A, Di Taranto R, et al. Neuropeptides in saliva of subjects with burning mouth syndrome: a pilot study. Oral Dis. 2010;16:365-374.
Zidverc-Trajkovic J, Stanimirovic D, Obrenovic R, et al. Calcitonin gene-related peptide levels in saliva of patients with burning mouth syndrome. J Oral Pathol Med. 2009;38:29-33.
Pekiner FN, Damirel GY, Gumru B, Ozbayrak S. Serum cytokine and T regulatory cell levels in patients with burning mouth syndrome. J Oral Pathol Med. 2008;37:528-534.
Srinivasan M, Kodumudi KN, Zunt SL. Soluble CD14 and toll-like receptor-2 are potential salivary biomarkers for oral lichen planus and burning mouth syndrome. Clin Immunol. 2008;126:31-37.
Jääskeläinen SK. Pathophysiology of primary burning mouth syndrome. Clin Neurophysiol. 2012;123:71-77.
Schiavone V, Adamo D, Ventrella G, et al. Anxiety, depression, and Pain in Burning Mouth Syndrome: First Chicken or Egg? Headache. 2012;52:1019-1025.
Lee GS, Kim HK, Kim ME. Relevance of sleep, pain cognition, and psychological distress with regard to pain in patients with burning mouth syndrome. CRANIO®. 2019;24:1-9.
Forssell H, Teerijoki-Oksa T, Puukka P, Estlander A-M. Symptom severity in burning mouth syndrome associates with psychological factors. J Oral Rehabil. 2020;47(6):713-719.
Currie CC, Jääskeläinen SK. Burning Mouth Syndrome: a review. Oral Surg. 2020;13(4):379-388. https://doi.org/10.1111/ors.12456
Dworkin RH, Turk DC, Revicki DA, et al. Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2). Pain. 2009;144:35-42.
Von Korff M, Ormel J, Keefe FJ, Dworkin SF. Grading the severity of chronic pain. Pain. 1992;50:133-149.
Devine M, Hirani M, Durham J, Nixdorf D, Renton T. Identifying criteria for diagnosis of post-traumatic pain and altered sensation of the maxillary and mandibular branches of the trigeminal nerve: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125:526-540.
Baad-Hansen L, Pigg M, Ivanovic SE, Faris H, List T, Svensson P. Chairside intraoral qualitative somatosensory testing: relability and comparison between patients with atypical odontalgia and healthy controls. J Orofac Pain. 2013;27:165-170.
Kroenke K, Spitzer RL, Williams JB, Lowe B. An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics. 2009;50:613-621.
Turner JA, Mancl L, Aaron LA. Pain-related catastrophizing: a daily process study. Pain. 2004;110:103-111.
Turner JA, Brister H, Huggins K, Mancl L, Aaron LA, Truelove EL. Catastrophizing is associated with clinical examination findings, activity interference, and health care use among patients with temporomandibular disorders. J Orofac Pain. 2005;19:291-300.
Spitzer RL, Williams JBW, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care: The PRIME-MD 1000 study. J Am Dent Assoc. 1994;272:1749-1756.
Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606-613.
Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatric Annals. 2002;32:509-521.
Löwe B, Unutzer J, Callahan CM, Perkins AJ, Kroenke K. Monitoring depression treatment outcomes with the Patient Health Questionnaire-9. Med Care. 2004;42:1194-1201.
Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch. Intern. Med. 2006;166:1092-1097. https://doi.org/10.1001/archinte.166.10.1092
Kroenke K, Spitzer RL, Williams JBW, Löwe B. The Patient Health Questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gen Hosp Psychiatr. 2010;32:345-359.
Kroenke K, Spitzer RL, Williams JBW. The PHQ-15: Validity of a new measure for evaluating somatic symptom severity. Psychosom Med. 2002;64:258-266.
Markiewicz MR, Ohrbach R, McCall WD. Oral Behaviors Checklist: Reliability of Performance in Targeted Waking- state Behaviors. J Orofac Pain. 2006;20:306-316.
Jääskeläinen SK, Woda A. Burning mouth syndrome. Cephalalgia. 2017;37:627-647.
Ariyawardana A, Chmieliauskaite M, Farag AM, et al. World workshop on oral medicine VII: Burning mouth syndrome: A systematic review of disease definitions and diagnostic criteria utilized in randomized clinical trials. Oral Dis. 2019;25:141-156.
Forssell H, Jääskeläinen S, List T, et al. An update on pathophysiological mechanisms related to idiopathic orofacial pain conditions with implications for management. J Oral Rehabil. 2015;42:300-322.

Auteurs

Charlotte C Currie (CC)

School of Dental Sciences, Newcastle University, Newcastle upon Tyne, UK.

Richard Ohrbach (R)

School of Dental Medicine, University at Buffalo, Buffalo, NY, USA.

Reny De Leeuw (R)

College of Dentistry, University of Kentucky, Lexington, KY, USA.

Heli Forssell (H)

Institute of Dentistry, University of Turku, Turku, Finland.

Yoshiki Imamura (Y)

Nihon University, Tokyo, Japan.

Satu K Jääskeläinen (SK)

Faculty of Medicine, University of Turku, Finland.

Michail Koutris (M)

Department of Orofacial pain and Dysfunction, Academic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam and Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Cibele Nasri-Heir (C)

Rutgers School of Dental Medicine, Newark, NJ, USA.

Tan Huann (T)

King's College London Dental Institute, London, UK.

Tara Renton (T)

King's College London Dental Institute, London, UK.

Peter Svensson (P)

Department of Dentistry and Oral Health, Aarhus University, Aarhus, Denmark.

Justin Durham (J)

School of Dental Sciences, Newcastle University, Newcastle upon Tyne, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH